货号：UP519049056
| 产品信息 | |
| 产品名称： | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate |
| 中文名称： | N-叔丁氧羰基哌啶-4-硼酸频哪醇酯(请以英文为准,中文仅做参考) |
| CAS号： | 1048970-17-7 |
| 分子式： | C16H30BNO4 |
| 分子量： | 311.23 |
| MDL NO： | MFCD09997792 |
| 标准纯度： | 97% (UP519049056) |
| 沸点： | 358.8°C at 760 mmHg |
| 储存： | Inert atmosphere,2-8°C (UP519049056) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
(5-(Benzyloxy)-2-fluorophenyl)boronic acid
UP4603699411217500-68-9
Lomeguatrib
UP239155508192441-08-0
Istaroxime hydrochloride
UP718409503374559-48-5
3-Benzyloxy-2-chloro-6-fluorophenylboronic acid
UP949736191957062-67-8
VTP-27999 Trifluoroacetate
UP8720245801013937-63-7
MK-2206 Dihydrochloride
UP1654595821032350-13-2
ARRY-162
UP793252738606143-89-9
BIX-02565
UP4639477991311367-27-7
SB-590885
UP651316197405554-55-4
NSC 23766 trihydrochloride
UP8304514131177865-17-6
Aliskiren
UP759503491173334-57-1
(S)-2-Amino-3-(1-methyl-1H-imidazol-5-yl)propanoic acid
UP470334898368-16-1
WEHI-539
UP2827677521431866-33-9
4-(4-Hydroxyphenyl)cyclohexanone
UP617792599105640-07-1
5-Boronoisophthalic acid
UP988201729881302-73-4
K-Ras G12C-IN-1
UP9476357621629265-17-3
3,5-Difluorobenzene-1-sulfonyl chloride
UP981882566210532-25-5
Guadecitabine
UP306082254929901-49-5
3,5-Difluorobenzenethiol
UP21226491799389-26-1
2,2'-((4-((4-Aminophenyl)diazenyl)phenyl)azanediyl)diethanol
UP87829278712222-69-4
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanol
UP3161993791040377-08-9
Nisoldipine
UP63157347363675-72-9
5-Azacytidine
UP473310310320-67-2
Fulvestrant
UP827069194129453-61-8
Raloxifene hydrochloride
UP40115764982640-04-8
INCB024360 Analogue
UP631299046914471-09-3
Benserazide Hydrochloride
UP55495004414919-77-8
4,4,5,5-Tetramethyl-2-(tetrahydrofuran-3-yl)-1,3,2-dioxaborolane
UP912583220331958-90-8
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
UP405805976850567-56-5
4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol Hydrochloride
UP92608938851-30-9
Propranolol Hydrochloride
UP264285595318-98-9
7-Fluoro-1,2,3,4-tetrahydrocyclopenta[b]indole
UP574088228327021-84-1
Niflumic acid
UP7190728564394-00-7
LJH685
UP7665361461627710-50-2
2-Chloro-1-(2,4-difluorophenyl)ethanone
UP85765788851336-94-8
3-Fluoro-4-methoxybenzeneboronic acid
UP596455842149507-26-6
Metoprolol succinate
UP19463467998418-47-4
4-Borono-3-fluorobenzoic acid
UP841406039851335-07-4
3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazole
UP6194899741314136-00-9
3,4-Dimethoxybenzoic acid
UP71254395593-07-2
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
UP653360604941685-26-3
IAA-94
UP42022253153108-00-2
PHTPP
UP713974722805239-56-9
Loteprednol etabonate
UP76115004082034-46-6
2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide
UP164032798936-16-3
Sodium 2-octadecylfumarate
UP9264539764070-80-8
MK-2894
UP8843729261006036-87-8
DC_517
UP843285066500017-70-9
Reserpine hydrochloride
UP81671278616994-56-2
Pseudotropine
UP465104204135-97-7
H-Ser(tBu)-OMe.HCl
UP57564876117114-97-5
Amlodipine
UP90568512188150-42-9
Lenalidomide hydrochloride
UP2933778241243329-97-6
RG108
UP82343794248208-26-0
TMEM16A Inhibitor C10bm
UP4048505892098490-06-1
Fmoc-Cys(Trt)-Wang resin 100-200 mesh, 1% DVB
UP969429746N/A
8-((4-Amino-2-nitrophenyl)diazenyl)-7-hydroxy-N,N,N-trimethylnaphthalen-2-aminium chloride
UP99935173768391-32-2
Procainamide hydrochloride
UP861238701614-39-1
Betrixaban
UP924839367330942-05-7
1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene
UP4461619626683-48-3
Fullerene C70
UP713155020115383-22-7
5,5,5',5'-Tetramethyl-2,2'-bi(1,3,2-dioxaborinane)
UP894015163201733-56-4
DCVC
UP41740698613419-46-0
Pregnenolone
UP791115235145-13-1
AdipoRon
UP601419609924416-43-3
(2-Isopropoxyphenyl)boronic acid
UP682593460138008-97-6
(2-Bromophenyl)boronic acid
UP633284361244205-40-1
Rostafuroxin
UP484341612156722-18-8
XCT790
UP911463353725247-18-7
tert-Butyldimethylsilyl (R)-(–)-glycidyl ether
UP574963340124150-87-4
Piceatannol
UP62486543110083-24-6
2-Fluoro-3-(trifluoromethyl)phenylboronic acid
UP633026063157834-21-4
Isobutylboronic acid
UP52386541484110-40-7
BI-D1870
UP683157370501437-28-1
(2-(Methoxycarbonyl)-1H-indol-5-yl)boronic acid
UP862513019284660-86-2
1-(Tetrahydrofuran-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
UP6217337141029715-63-6
Deguelin
UP345923380522-17-8
Acetazolamide
UP53167676159-66-5
SGC707
UP3544594881687736-54-4
NSC 23766
UP836598848733767-34-5
Kobe0065
UP175999821436133-68-5
Esuberaprost Sodium
UP34369396488475-69-8
BIX-01294
UP122937197935693-62-2
2-Hydroxyphenylboronic acid
UP63398306589466-08-0
Dydrogesterone
UP533695657152-62-5
Reserpine
UP78373648150-55-5
Carbidopa
UP86651755628860-95-9
Boc-Ala-Osu
UP3180983953392-05-0
Pluripotin
UP608516665839707-37-8
Boc-N-Ethylglycine
UP701047990149794-10-5
GSK481
UP3600794531622849-58-4
Methazolamide
UP670025978554-57-4
WAY-362450
UP923611617629664-81-9
Centrinone
UP7609897711798871-30-3
(2,3,4-Trimethoxyphenyl)boronic acid
UP678386536118062-05-8
AA26-9
UP9581317951312782-34-5
AS-703026
UP1276894201236699-92-5
Trilostane
UP59134381613647-35-3
Glucose-conjugated MGMT inhibitor
UP291559118382607-78-5
Beclometasone dipropionate
UP4291404645534-09-8
(2-Chlorophenyl)boronic acid
UP6531941323900-89-8
(1S,3R)-3-Aminocyclohexanecarboxylic acid hydrochloride
UP185366182N/A
2-Bromo-5-methoxybenzene boronic acid
UP68453711589694-44-0
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate
UP5190490561048970-17-7